TCM
LLY icon

Telos Capital Management’s Eli Lilly LLY Stock Holding History

Telos Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76M Buy
2,302
+1
+0% +$1.02K 0.24% 90
2026
Q1 		$2.12M Sell
2,301
-30
-1% -$30.4K 0.2% 89
2025
Q4 		$2.51M Sell
2,331
-154
-6% -$147K 0.23% 92
2025
Q3 		$1.9M Sell
2,485
-795
-24% -$592K 0.18% 95
2025
Q2 		$2.56M Buy
3,280
+1,298
+65% +$1.01M 0.26% 91
2025
Q1 		$1.64M Sell
1,982
-5
-0.3% -$4.16K 0.18% 98
2024
Q4 		$1.53M Buy
1,987
+371
+23% +$307K 0.16% 99
2024
Q3 		$1.43M Hold
1,616
– – 0.15% 105
2024
Q2 		$1.46M Sell
1,616
-70
-4% -$56K 0.16% 97
2024
Q1 		$1.31M Sell
1,686
-3,855
-70% -$2.74M 0.15% 104
2023
Q4 		$3.23M Sell
5,541
-160
-3% -$93.4K 0.39% 76
2023
Q3 		$3.06M Hold
5,701
– – 0.43% 72
2023
Q2 		$2.67M Sell
5,701
-159
-3% -$66.7K 0.36% 79
2023
Q1 		$2.01M Sell
5,860
-5
-0.1% -$1.69K 0.28% 87
2022
Q4 		$2.15M Sell
5,865
-177
-3% -$62.8K 0.31% 88
2022
Q3 		$1.95M Sell
6,042
-1,125
-16% -$356K 0.32% 86
2022
Q2 		$2.32M Hold
7,167
– – 0.36% 85
2022
Q1 		$2.05M Sell
7,167
-100
-1% -$25.7K 0.27% 93
2021
Q4 		$2.01M Sell
7,267
-100
-1% -$25.4K 0.25% 90
2021
Q3 		$1.7M Hold
7,367
– – 0.23% 99
2021
Q2 		$1.69M Sell
7,367
-1,735
-19% -$349K 0.22% 101
2021
Q1 		$1.7M Buy
9,102
+160
+2% +$31.3K 0.24% 98
2020
Q4 		$1.51M Buy
8,942
+40
+0.4% +$5.97K 0.23% 97
2020
Q3 		$1.32M Hold
8,902
– – 0.23% 95
2020
Q2 		$1.46M Sell
8,902
-50
-0.6% -$7.67K 0.28% 91
2020
Q1 		$1.24M Buy
8,952
+5,638
+170% +$775K 0.31% 91
2019
Q4 		$436K Buy
3,314
+250
+8% +$29K 0.1% 132
2019
Q3 		$343K Buy
3,064
+883
+40% +$98.3K 0.09% 135
2019
Q2 		$242K Sell
2,181
-80
-4% -$9.42K 0.07% 143
2019
Q1 		$293K Sell
2,261
-125
-5% -$15.2K 0.09% 128
2018
Q4 		$276K Buy
2,386
+191
+9% +$21.3K 0.1% 126
2018
Q3 		$236K Sell
2,195
-300
-12% -$30K 0.08% 146
2018
Q2 		$213K Buy
+2,495
New +$205K 0.07% 146

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Telos Capital Management's LLY Position: Q2 2026 in Review

Telos Capital Management increased its Eli Lilly (LLY) stake by 0.04% in Q2 2026, buying an estimated $1.02K and bringing the position to 2,302 shares worth $2.76M. The position accounts for 0.24% of the portfolio, ranked #90.

Telos Capital Management first reported a position in LLY in Q2 2018 and has held it in 33 quarters since. The position peaked at $3.23M in Q4 2023. 1,674 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Telos Capital Management held 2,302 shares of Eli Lilly worth $2.76M as of Q2 2026.
  • Telos Capital Management bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.24% of Telos Capital Management's portfolio in Q2 2026, its #90 holding.
  • Telos Capital Management first reported a position in Eli Lilly in Q2 2018 and has held it in 33 quarters since.
  • Telos Capital Management's Eli Lilly position peaked at $3.23M in Q4 2023.
  • 1,674 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Telos Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.